Shanghai Aladdin Biochemical Technology Co.,Ltd.
Firmenname:
Shanghai Aladdin Biochemical Technology Co.,Ltd.
Telefon:
400-6206333
E-Mail:
market@aladdin-e.com
Nationalität:
China
URL:
www.aladdin-e.com/
Produkte insgesamt:
48466
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
Produktkatalog
Dehydroepiandrosterone sulfate
651-48-9
C19H28O5S
8-Azahypoxanthine
4,5-Dihydro-1H-triazolo[4,5-d]pyrimidin-4-ol
2683-90-1
C4H3N5O
Eculizumab (anti-Complement C5)
219685-50-4
Sirukumab (anti-IL-6)
1194585-53-9
Bimagrumab (anti-ACVR2B)
1356922-05-8
Ulocuplumab (anti-CXCR4)
1375830-34-4
Abelacimab(anti-Factor XI)
2098724-83-3
Tesnatilimab (anti-NKG2D)
2242758-08-1
Zansecimab (anti-ANGPT2)
2415205-37-5
Meropenem-d6
1133424-00-6
C17H25N3O5S
Ranibizumab (anti-VEGFA)
347396-82-1
C11H12N2O2
2-(azetidin-1-yl)ethan-1-amine
795299-77-3
C5H12N2
Enoblituzumab (anti-CD276)
1353485-38-7
Flanvotumab (anti-TYRP1)
1188277-05-5
Bermekimab (anti-IL-1a)
1401965-15-8
Inebilizumab (anti-CD19)
1299440-37-1
Prezalumab (anti-B7-H2)
1523164-68-2
Depatuxizumab mafodotin (anti-EGFR)
1585973-65-4
Tinurilimab (anti-CEACAM6)
2226224-30-0
Vandortuzumab (anti-STEAP1)
1557989-52-2
Galiximab (anti-CD80)
357613-77-5
Ethyl 2-oxo-4-phenylbutyrate
Ethyl-2-oxo-4-phenylbutyrat
64920-29-2
C12H14O3
Pascolizumab (anti-IL-4)
331243-22-2
Ocrelizumab (anti-CD20)
637334-45-3
C19H16N2O5
Bis(hexamethylene)triamine
7-Azatridecan-1,13-diamin
143-23-7
C12H29N3
Ixekizumab (anti-CTLA-8)
1143503-69-8
Enokizumab (anti-IL-9)
909875-08-7
Concizumab (anti-TFPI)
1312299-39-0
Tarextumab (anti-NOTCH3)
1359940-55-8
Emibetuzumab (anti-MET)
1365287-97-3
Tesidolumab (anti-Complement C5)
1531594-08-7
Xentuzumab (anti-IGF1)
1417158-65-6
Lacnotuzumab (anti-M-CSF)
1831128-32-5
Ladiratuzumab (anti-SLC39A6)
1629760-28-6
Narsoplimab (anti-MASP2)
2108782-45-0
Belimumab (anti-TNFSF13B)
356547-88-1
IDO-IN-13
2291164-02-6
C26H17F3N4O
Benzyldiphenylphosphine
7650-91-1
C19H17P
Alizarin Yellow R sodium salt
Natrium-5-[(4-nitrophenyl)azo]salicylat
1718-34-9
C13H8N3NaO5
Eldelumab (anti-CXCL10)
946414-98-8
Tisotumab (anti-F3)
1418628-81-5
Vopratelimab (anti-ICOS)
2039148-04-2
Ragifilimab (anti-TNFRSF18)
2207590-51-8
Daclizumab (anti-IL2RA)
152923-56-3
Sonepcizumab (anti-Sphingosine-1-phosphate)
1031360-18-5
Rilotumumab (anti-HGF)
872514-65-3
Narnatumab (anti-RON)
1188275-92-4
Carotuximab (anti-CD105)
1268714-50-6
Brazikumab (anti-IL-23)
1610353-18-8
Ontamalimab (anti-MADCAM1)
2098790-40-8
Dostarlimab (anti-PD-1)
2022215-59-2
Avdoralimab (anti-C5AR1)
2226393-85-5
Datopotamab (anti-TROP2)
2267989-53-5
Denintuzumab (anti-CD19)
1630074-14-4
Mogamulizumab (anti-CCR4)
1159266-37-1
Rosmantuzumab (anti-RSPO3)
1684393-04-1
Ianalumab (anti-TNFRSF13C)
1929549-92-7
Quetmolimab (anti-CX3CL1)
2084037-83-0
Gemtuzumab (anti-CD33)
220578-59-6
Telazorlimab (anti-TNFRSF4)
2126777-87-3
Imazapic
104098-48-8
C14H17N3O3
Guselkumab (anti-IL-23)
1350289-85-8
Labetuzumab govitecan (anti-CEACAM5)
1469876-18-3
Apamistamab (anti-PTPRC)
2097132-02-8
Sirtratumab (anti-SLITRK6)
1824663-82-2
Nadecnemab (anti-GFRA3)
2377679-19-9
Dysprosium(III) trifluoromethanesulfonate
139177-62-1
C3DyF9O9S3
Efalizumab (anti-ITGAL)
214745-43-4
Elotuzumab (anti-SLAMF7)
915296-00-3
Oxelumab (anti-TNFSF4)
1186098-83-8
Seribantumab (anti-ERBB3)
1334296-12-6
Zagotenemab (anti-Tau)
2019133-28-7
Bexmarilimab (anti-STAB1)
2259301-27-2
Lemzoparlimab (anti-CD47)
2377483-71-9
Enfortumab (anti-NECTIN4)
1448664-46-7
KWAR23 (anti-SIRPg)
2243227-60-1
Lexatumumab (anti-TNFRSF10B)
845816-02-6
Bivatuzumab (anti-CD44v6)
214559-60-1
Urelumab (anti-TNFRSF9)
934823-49-1
Dinutuximab (anti-GD2)
1363687-32-4
Ravulizumab (anti-Complement C5)
1803171-55-2
Apelin 17 TFA
217082-57-0
C96H156N34O20S
Lumiliximab (anti-FceR2)
357613-86-6
Otilimab (anti-GM-CSF)
1638332-55-4
Fulranumab (anti-NGF)
902141-80-4
Vorsetuzumab (anti-CD70)
1165740-62-4
Vantictumab (anti-FZD)
1345009-45-1
Indusatumab (anti-GUCY2C)
1497400-26-6
Tamrintamab (anti-DPEP3)
2148325-59-9
Cinpanemab (anti-Alpha-synuclein)
2094516-02-4
Daxdilimab (anti-ILT7)
2245966-28-1
Idactamab (anti-SLC1A5)
2245205-37-0
Ponsegromab (anti-GDF15)
2368950-15-4
Gevokizumab (anti-IL-1b)
1129435-60-4
Itolizumab (anti-CD6)
1116433-11-4
Girentuximab (anti-CA9)
916138-87-9
Codrituzumab (anti-GPC3)
1365267-33-9
Vunakizumab (anti-IL-17a)
1792181-33-9
Imaprelimab (anti-CD146)
2014343-04-3
Serplulimab (anti-PDCD1)
2231029-82-4
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
Copyright 2019 © ChemicalBook. All rights reserved